Faculty profile

Matthew Cheung

Back to faculty

ProfessorDepartment of MedicineUniversity of Toronto

Matthew Cheung

Professor

Department of Medicine

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
115 publications in the last five years, latest in 2026.
Senior (last) author on 10 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2020.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

412

Publications

5,578

Citations

423

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Chronic Lymphocytic Leukemia Non-Inferiority Randomized Controlled Trial Toxicity Economics Quality Of Life De-Escalation

Latest papers

Outcomes of transplant-eligible and transplant-ineligible patients with mantle cell lymphoma in Ontario.
Blood neoplasia · 2026
Structured Exercise Program After Adjuvant Chemotherapy for Colon Cancer: A Cost-Utility Analysis of the CHALLENGE Trial
Journal of Clinical Oncology · 2026
Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1
Journal of Clinical Oncology · 2026

All 412 publications

Latest funding

Hypofractionated Alternative Radiation with MOdulation of Neoadjuvant/perioperative immunotherapY in Sarcoma (HARMONY)
CIHR · 2025 · Co-investigator
$1,407,600
RATIONAL (Role of Antibiotic Therapy or Immunoglobulin On iNfection in hAematoLogy) Platform Trial: An RCT of continuing immunoglobulin therapy, or stopping with or without prophylactic antibiotics, on infection rate in patients with acquired hypogammaglobulinemia secondary to haematological malignancies
CIHR · 2024 · Co-investigator
$1,197,227
A Phase III Non-Inferiority Randomized Controlled Trial (RCT) of Fixed-Duration Daratumumab Versus Continuous Daratumumab Among Transplant Ineligible Older Adults with Newly-Diagnosed Multiple Myeloma
CIHR · 2023 · Co-investigator
$3,056,172

All 9 grants and awards

From the 150 most recent of 412 publications.

Outcomes of transplant-eligible and transplant-ineligible patients with mantle cell lymphoma in Ontario.

Suleman A, Ante Z, Liu N, Crump M, Chan KKW, Cheung MC, Prica A

Blood neoplasia20261 citationsOpen Access

DOI: 10.1016/j.bneo.2025.100184 PMID: 41994328

Structured Exercise Program After Adjuvant Chemotherapy for Colon Cancer: A Cost-Utility Analysis of the CHALLENGE Trial

Chan KKW, Chu RWK, Cheung MC, Courneya KS, O'Callaghan CJ, Vardy JL, Gill S, Friedenreich C, Wong RKS, Dhillon HM

Journal of Clinical Oncology20261 citationsOpen Access

DOI: 10.1200/jco-26-00765

Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1

Banerjee R, Cheung MC, Derman B, Messersmith H, Al Hadidi S, Bhella S, Chmielewski C, Ebraheem MS, Kennedy CT, Kumar S

Journal of Clinical Oncology20261 citationsOpen Access

DOI: 10.1200/jco-26-01139

Frailty and health resource utilization in 5450 adults with acute myeloid leukaemia: A population-based study from Ontario, Canada.

Gupta G, Podolsky S, Liu N, Cheung MC, Bankar A

British journal of haematology2026Open Access

DOI: 10.1111/bjh.70600 PMID: 42259647

Comparative effectiveness of chimeric antigen receptor (CAR) T‐cell therapy versus historical controls in patients with relapse/refractory aggressive B‐cell lymphoma: An indirect treatment comparison in the real‐world setting

Villeneuve PJA, Mozessohn L, Somé NH, Mercer RE, Masucci L, Kouroukis T, Bredeson C, Aktar S, Guan Q, Prica A

British Journal of Haematology2026Open Access

DOI: 10.1111/bjh.70632

A Prospective Population-Based Study of Chimeric Antigen Receptor T-Cell Therapy for Patients with Diffuse Large B-Cell Lymphoma

Mozessohn L, Villeneuve PJA, Somé NH, Mercer RE, Masucci L, Kouroukis T, Bredeson C, Aktar S, Guan Q, Prica A

Current Oncology2026Open Access

DOI: 10.3390/curroncol33060366

Structured exercise program following adjuvant chemotherapy for colon cancer: A cost-utility analysis of the CHALLENGE trial.

Chan KK, Chu RW, Cheung MC, Courneya KS, O'Callaghan CJ, Vardy JL, Gill S, Friedenreich C, Wong RK, Dhillon HM

Journal of Clinical Oncology2026

DOI: 10.1200/jco.2026.44.16_suppl.3507

Abstract 7319: Targeting HDAC1 activity presents vulnerabilities in pancreatic cancer metabolism

Don-Gerard Conde, Evan J. Zhou, Soren Jensen, Maximillian Farma, Chiamaka Joy Ezeh, Alexander N. Behram, Phuong T. Pham, Nabila N. Binti, Laiba Shiekh, Matthew C. Cheung, Zeribe C. Nwosu

Cancer Research2026

DOI: 10.1158/1538-7445.am2026-7319

ASH clinical practice guidelines: evaluation of discordance between certainty of evidence and strength of recommendations

Hershenfeld SA, Kunkle R, Pai M, Cuker A, Cheung MC

Blood advances2026Senior authorOpen Access

DOI: 10.1182/bloodadvances.2026020781

Evaluating the incidence and predictors of chronic opioid use in early survivorship for patients with diffuse large B-cell lymphoma.

Ravindran M, Peng J, Zipursky J, Luo J, Liu N, Chan KKW, Cheung MC, Mozessohn L

Journal of the National Cancer Institute2026Open Access

DOI: 10.1093/jnci/djag305 PMID: 42679364

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Matthew Cheung

Research

Latest papers

Latest funding

Outcomes of transplant-eligible and transplant-ineligible patients with mantle cell lymphoma in Ontario.

Structured Exercise Program After Adjuvant Chemotherapy for Colon Cancer: A Cost-Utility Analysis of the CHALLENGE Trial

Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1

Frailty and health resource utilization in 5450 adults with acute myeloid leukaemia: A population-based study from Ontario, Canada.

Comparative effectiveness of chimeric antigen receptor (CAR) T‐cell therapy versus historical controls in patients with relapse/refractory aggressive B‐cell lymphoma: An indirect treatment comparison in the real‐world setting

A Prospective Population-Based Study of Chimeric Antigen Receptor T-Cell Therapy for Patients with Diffuse Large B-Cell Lymphoma

Structured exercise program following adjuvant chemotherapy for colon cancer: A cost-utility analysis of the CHALLENGE trial.

Abstract 7319: Targeting HDAC1 activity presents vulnerabilities in pancreatic cancer metabolism

ASH clinical practice guidelines: evaluation of discordance between certainty of evidence and strength of recommendations

Evaluating the incidence and predictors of chronic opioid use in early survivorship for patients with diffuse large B-cell lymphoma.

Frequent collaborators

Kelvin Chan

Simron Singh

Nicole Mittmann

Ning Liu

Kevin Imrie

Lee Mozessohn

Lisa Hicks

Annette Hay

Maureen Trudeau

John Kuruvilla

Bingshu Chen

Anca Prica

Inna Gong

Lisa Chodirker

Ralph Meyer

Ryan Morin

Tom Kouroukis

William Evans

Rena Buckstein

David Spaner

Abi Vijenthira

Michael Crump

Vishal Kukreti

Natasha Leighl

Nicole Hong

Jean-François Larouche

Vikas Gupta

Kitty Chan

Dale Brown

Jim Woodgett

Ming Tsao

Anastasia Oikonomou

Ur Metser

Ebba Kurz

Qi-Ming He

Saima Hassan

Refik Saskin

Jennifer Teichman

Peter Cram

Sarah Engelhart